Malta urges action on synthetic cannabis risks

The Medical Association of Malta (MAM) has issued a strong warning to the public about the health dangers posed by edible cannabis products containing a synthetic compound known as CC9. This alert follows a spike in hospital cases involving individuals who had consumed these edibles—commonly sold in the form of gummies, cakes, and cookies—only to suffer from a range of serious side effects.

MAM has reported that in recent weeks, several individuals were admitted to hospital after ingesting these products, with symptoms including extended periods of intense drowsiness, vomiting, visual disturbances, and liver complications.

Understanding CC9 and how it differs from THC

CC9 belongs to the category of synthetic cannabinoids—laboratory-created substances designed to simulate the psychoactive effects of THC, the primary active component of cannabis. However, CC9 is entirely synthetic and does not exist in natural cannabis plants.

Although CC9 binds to the same cannabinoid receptors in the brain as THC, its chemical structure is different, which can result in distinct and often unexpected effects. This key difference increases the unpredictability and potential danger of using CC9 compared to naturally occurring cannabis compounds.

Adverse effects and health risks from CC9-laced edibles

Those who consumed CC9-laced products in Malta have reported particularly severe reactions. In addition to physical symptoms such as vomiting and persistent sleepiness, users also experienced blurred vision and signs of liver dysfunction. Health professionals warn that the psychoactive impact of CC9 can be far more intense and longer-lasting than traditional cannabis.

Because edibles are processed by the body differently than inhaled cannabis, users may not immediately feel the effects. This often leads to overconsumption, resulting in an unexpectedly powerful and prolonged high—especially dangerous when the product contains an unregulated compound like CC9.

MAM condemns misleading marketing practices

“These products are being sold with misleading ‘NOT for human consumption' labels while clearly being marketed for exactly that purpose. MAM condemns this dangerous practice – these substances completely bypass the rigorous safety testing and clinical trials required by European Medicines Agency regulations, putting consumers at serious risk,” the MAM said.

These deceptive labels allow sellers to avoid regulatory oversight, despite packaging and branding that clearly aim to attract recreational users. MAM has sharply criticised the practice, calling for tighter enforcement against such misleading tactics.

Cannabis use and mental health concerns

MAM used this opportunity to highlight broader concerns about cannabis usage, especially its impact on mental health.

“It emphasised cannabis consumption impairs coordination, judgment, and reaction time. ‘Furthermore, substantial scientific evidence links cannabis use to serious mental health problems, including anxiety, depression, and in some cases, psychosis, particularly among young and vulnerable users,’ it said.”

While the debate over legal cannabis continues in many parts of the world, including Malta, MAM is drawing attention to the need to distinguish between regulated substances and dangerous synthetic variants like CC9.

Unpredictable duration and intensity of CC9 effects

“It stated the effects of CC9 lasts much longer than users anticipate.”

Unlike the more predictable effects of regulated cannabis, the influence of synthetic cannabinoids like CC9 can be erratic and drawn out. This adds to the risk for users who are unaware of what they are consuming or how their body will react.

Urging immediate government response

“MAM calls for immediate government action to remove these dangerous products from sale and hold accountable those who profit from putting public health at risk,” the MAM said.

The association is urging authorities to take swift and decisive action, not only to remove these items from circulation but also to investigate and penalise those responsible for distributing them. MAM has highlighted the urgent need for updated legislation that can close existing legal loopholes being exploited by vendors of synthetic cannabis products.

Regulatory gaps in Malta and Europe

This situation brings to light regulatory weaknesses in Malta’s drug policy framework. While certain cannabis products are permitted under medical or recreational laws, synthetic compounds like CC9 often escape these legal definitions, making enforcement more difficult.

Such substances are often introduced to the market faster than regulators can classify and ban them. MAM’s call to action underlines the need for proactive regulation and a responsive legal system that can quickly adapt to emerging threats in the drug market.

Healthcare sector calls for increased awareness

As synthetic drugs become more prevalent, healthcare workers in Malta are increasingly dealing with patients affected by these substances. MAM has called for enhanced training for medical professionals to better identify and manage cases involving synthetic cannabinoids.

The association has also proposed that public health campaigns be rolled out to educate the public—particularly young people—about the dangers of products like CC9, which are often disguised as harmless treats.

A European and global concern

The spread of synthetic cannabinoids is a growing issue worldwide. Many European nations, along with countries in North America, are experiencing similar public health challenges as new synthetic drugs continue to emerge. These substances are frequently marketed as legal or safer alternatives to cannabis, despite lacking any form of scientific validation or safety assurances.

Organisations such as the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have been monitoring the rapid evolution of synthetic drug markets, with dozens of new compounds appearing annually. Malta’s handling of the CC9 situation may offer valuable lessons for other countries facing similar regulatory dilemmas.

From drug policy to urgent public health crisis

This incident reinforces the notion that the synthetic cannabis issue is not merely a matter of recreational drug use—it has escalated into a significant public health concern. The high potential for severe physical and psychological side effects, combined with misleading product marketing and lack of regulatory oversight, calls for a multi-sector response.

MAM’s appeal reflects the growing consensus that synthetic cannabinoids should not be treated as equivalent to natural cannabis and that targeted, evidence-based responses are needed to address this rising threat.

Conclusion

The rise in hospitalisations linked to synthetic cannabis products containing CC9 has raised significant concerns among medical professionals in Malta. These synthetic substances, often sold deceptively as harmless edibles, are proving to be far more dangerous than users may anticipate. The unpredictable and prolonged effects of CC9, coupled with misleading marketing practices, highlight the urgent need for stricter regulations and more effective enforcement in the cannabis product market. As synthetic cannabinoids continue to emerge and evade legal frameworks, it is essential for both public health authorities and consumers to be aware of the serious risks involved. Immediate action is necessary to protect the health and well-being of individuals, particularly vulnerable populations, while ensuring that the market for cannabis products remains safe and regulated. The call from the Medical Association of Malta for government intervention is a crucial step toward safeguarding public health and preventing further harm.

FAQs

What is CC9 and how does it compare to THC?
CC9 is a synthetic cannabinoid designed to imitate THC, the psychoactive compound in cannabis. Unlike THC, CC9 is man-made and can have more unpredictable and dangerous effects.

What makes CC9-laced edibles hazardous?
They can cause symptoms like prolonged sedation, vomiting, liver damage, and visual impairment. The effects may be more intense and last much longer than expected.

How are CC9 products being sold?
Typically sold as edibles—like gummies or cookies—these items often carry labels saying “NOT for human consumption,” which misleads consumers and regulators alike.

Is CC9 legal in Malta?
It may fall into a grey legal area, as synthetic cannabinoids are not always specifically addressed in existing drug laws. MAM is calling for stronger enforcement and clear regulation.

Why is the Medical Association of Malta concerned?
The group has observed a growing number of hospitalisations linked to CC9 and is urging the government to ban such products and protect public health.

Can synthetic cannabinoids cause mental health issues?
Yes, frequent use has been linked to anxiety, depression, and psychosis, especially among young users and those predisposed to mental illness.

How long do the effects of CC9 last?
MAM has noted that the psychoactive effects of CC9 often persist longer than users expect, increasing the risk of serious health outcomes.

Are synthetic edibles tested for safety?
No, they often bypass any formal testing or quality control, making them especially dangerous compared to regulated medical cannabis products.

What should someone do if they feel unwell after consuming CC9?
They should seek immediate medical attention. Symptoms like extreme drowsiness, nausea, or vision issues may require urgent care.

What steps is MAM recommending?
MAM wants the government to ban the sale of CC9 products, hold distributors accountable, and launch awareness campaigns to inform the public.